Next Article in Journal
A Biochemical Approach to Detect Oxidative Stress in Infertile Women Undergoing Assisted Reproductive Technology Procedures
Next Article in Special Issue
A Comprehensive Analysis of Argonaute-CLIP Data Identifies Novel, Conserved and Species-Specific Targets of miR-21 in Human Liver and Hepatocellular Carcinoma
Previous Article in Journal
Multifaceted Mechanisms of Cisplatin Resistance in Long-Term Treated Urothelial Carcinoma Cell Lines
Previous Article in Special Issue
Alteration of Epigenetic Regulation by Long Noncoding RNAs in Cancer
Open AccessArticle

Luminal lncRNAs Regulation by ERα-Controlled Enhancers in a Ligand-Independent Manner in Breast Cancer Cells

Center for Molecular Systems Biology, University of Turin, Orbassano, 10043 Turin, Italy
Department of Clinical and Biological Sciences, University of Turin, Orbassano, 10043 Turin, Italy
Department of Computer Science, University of Turin, 10149 Turin, Italy
Italian Institute for Genomic Medicine (IIGM), 10126 Turin, Italy
Author to whom correspondence should be addressed.
These authors contribute equally to the work.
Current address: Istituto Nazionale di Genetica Molecolare INGM, 20122 Milan, Italy
Current address: Novo Nordisk Foundation, Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, DK-2200 Copenhagen, Denmark
Int. J. Mol. Sci. 2018, 19(2), 593;
Received: 29 December 2017 / Revised: 7 February 2018 / Accepted: 14 February 2018 / Published: 16 February 2018
Estrogen receptor-α (ERα) is a ligand-inducible protein which mediates estrogenic hormones signaling and defines the luminal BC phenotype. Recently, we demonstrated that even in absence of ligands ERα (apoERα) binds chromatin sites where it regulates transcription of several protein-coding and lncRNA genes. Noteworthy, apoERα-regulated lncRNAs marginally overlap estrogen-induced transcripts, thus representing a new signature of luminal BC genes. By the analysis of H3K27ac enrichment in hormone-deprived MCF-7 cells, we defined a set of Super Enhancers (SEs) occupied by apoERα, including one mapped in proximity of the DSCAM-AS1 lncRNA gene. This represents a paradigm of apoERα activity since its expression is largely unaffected by estrogenic treatment, despite the fact that E2 increases ERα binding on DSCAM-AS1 promoter. We validated the enrichment of apoERα, p300, GATA3, FoxM1 and CTCF at both DSCAM-AS1 TSS and at its associated SE by ChIP-qPCR. Furthermore, by analyzing MCF-7 ChIA-PET data and by 3C assays, we confirmed long range chromatin interaction between the SE and the DSCAM-AS1 TSS. Interestingly, CTCF and p300 binding showed an enrichment in hormone-depleted medium and in the presence of ERα, elucidating the dynamics of the estrogen-independent regulation of DSCAM-AS1 expression. The analysis of this lncRNA provides a paradigm of transcriptional regulation of a luminal specific apoERα regulated lncRNA. View Full-Text
Keywords: lncRNA; super enhancer; estrogen receptor; breast cancer lncRNA; super enhancer; estrogen receptor; breast cancer
Show Figures

Graphical abstract

MDPI and ACS Style

Miano, V.; Ferrero, G.; Rosti, V.; Manitta, E.; Elhasnaoui, J.; Basile, G.; De Bortoli, M. Luminal lncRNAs Regulation by ERα-Controlled Enhancers in a Ligand-Independent Manner in Breast Cancer Cells. Int. J. Mol. Sci. 2018, 19, 593.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop